Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Bicycle Therapeutics (BCYC) over the last 7 years, with Q3 2025 value amounting to 0.45%.

  • Bicycle Therapeutics' Return on Invested Capital fell 2300.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 2300.0%. This contributed to the annual value of 0.35% for FY2024, which is 2400.0% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Return on Invested Capital of 0.45% as of Q3 2025, which was down 2300.0% from 0.4% recorded in Q2 2025.
  • Bicycle Therapeutics' Return on Invested Capital's 5-year high stood at 0.22% during Q3 2024, with a 5-year trough of 0.65% in Q2 2023.
  • Over the past 5 years, Bicycle Therapeutics' median Return on Invested Capital value was 0.41% (recorded in 2021), while the average stood at 0.39%.
  • In the last 5 years, Bicycle Therapeutics' Return on Invested Capital tumbled by -3800bps in 2023 and then skyrocketed by 3600bps in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Return on Invested Capital (Quarter) stood at 0.25% in 2021, then crashed by -73bps to 0.43% in 2022, then dropped by -11bps to 0.48% in 2023, then soared by 47bps to 0.25% in 2024, then crashed by -78bps to 0.45% in 2025.
  • Its Return on Invested Capital stands at 0.45% for Q3 2025, versus 0.4% for Q2 2025 and 0.32% for Q1 2025.